Published on 10/6/2023 in the Prospect News Structured Products Daily.
New Issue: UBS prices $99,985 14.18% trigger yield optimization notes on Moderna
New York, Oct. 6 – UBS AG, London Branch priced $99,985.34 of 14.18% trigger yield optimization notes due Oct. 9, 2024 linked to the common stock of Moderna Inc, according to a 424B2 filing with the Securities and Exchange Commission.
The face amount of each note is $104.26, which is equal to the initial share price of Moderna stock.
Interest is payable monthly.
The payout at maturity will be par unless the final price of Moderna stock is less than 70% of the initial share price, in which case investors will receive a cash payment per note equal to the final price.
UBS Financial Services Inc. and UBS Investment Bank are the underwriters.
Issuer: | UBS AG, London Branch
|
Issue: | Trigger yield optimization notes
|
Underlying stock: | Moderna Inc
|
Amount: | $99,985.34
|
Maturity: | Oct. 9, 2024
|
Coupon: | 14.18%, payable monthly
|
Price: | Par of $104.26
|
Payout at maturity: | If final share price is less than trigger price, cash amount equal to final price; otherwise, par
|
Initial share price: | $104.26
|
Trigger price: | $72.98, 70% of initial price
|
Pricing date: | Oct. 4
|
Settlement date: | Oct. 6
|
Underwriters: | UBS Financial Services Inc. and UBS Investment Bank
|
Fees: | 2%
|
Cusip: | 90301Y631
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.